Northern Trust
PMVP icon

Northern Trust’s PMV Pharmaceuticals PMVP Stock Holding History

Northern Trust’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Sell
115,422
-266,666
-70% -$339K ﹤0.01% 4030
2025
Q4 		$478K Buy
382,088
+1,275
+0.3% +$1.71K ﹤0.01% 3671
2025
Q3 		$533K Buy
380,813
+265,156
+229% +$367K ﹤0.01% 3627
2025
Q2 		$123K Buy
115,657
+8,311
+8% +$8.15K ﹤0.01% 4065
2025
Q1 		$117K Buy
107,346
+6
+0% +$8 ﹤0.01% 4080
2024
Q4 		$162K Buy
107,340
+20,190
+23% +$32K ﹤0.01% 4047
2024
Q3 		$130K Sell
87,150
-236,560
-73% -$365K ﹤0.01% 3995
2024
Q2 		$524K Sell
323,710
-14,424
-4% -$26K ﹤0.01% 3493
2024
Q1 		$575K Buy
338,134
+10,910
+3% +$20.4K ﹤0.01% 3520
2023
Q4 		$1.01M Sell
327,224
-12,505
-4% -$33.1K ﹤0.01% 3310
2023
Q3 		$2.09M Buy
339,729
+18,931
+6% +$130K ﹤0.01% 2915
2023
Q2 		$2.01M Buy
320,798
+12,292
+4% +$64.4K ﹤0.01% 3001
2023
Q1 		$1.47M Sell
308,506
-12,227
-4% -$86K ﹤0.01% 3078
2022
Q4 		$2.79M Buy
320,733
+4,215
+1% +$44.9K ﹤0.01% 2818
2022
Q3 		$3.77M Buy
316,518
+3,381
+1% +$48.8K ﹤0.01% 2658
2022
Q2 		$4.46M Buy
313,137
+67,379
+27% +$981K ﹤0.01% 2594
2022
Q1 		$5.12M Sell
245,758
-3,535
-1% -$62.4K ﹤0.01% 2575
2021
Q4 		$5.76M Sell
249,293
-3,783
-1% -$91.4K ﹤0.01% 2606
2021
Q3 		$7.54M Sell
253,076
-6,439
-2% -$206K ﹤0.01% 2474
2021
Q2 		$8.87M Buy
259,515
+97,688
+60% +$3.26M ﹤0.01% 2455
2021
Q1 		$5.32M Buy
161,827
+5,549
+4% +$219K ﹤0.01% 2706
2020
Q4 		$9.61M Buy
156,278
+140,300
+878% +$5.5M ﹤0.01% 2267
2020
Q3 		$567K Buy
+15,978
New +$588K ﹤0.01% 3577

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Northern Trust's PMVP Position: Q1 2026 in Review

Northern Trust reduced its PMV Pharmaceuticals (PMVP) stake by 70% in Q1 2026, selling an estimated $339K and leaving 115,422 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

Northern Trust first reported a position in PMVP in Q3 2020 and has held it in 23 quarters since. The position peaked at $9.61M in Q4 2020. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Northern Trust held 115,422 shares of PMV Pharmaceuticals worth $143K as of Q1 2026.
  • Northern Trust sold 266,666 PMV Pharmaceuticals shares in Q1 2026, an estimated $339K.
  • PMV Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4030 holding.
  • Northern Trust first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Northern Trust's PMV Pharmaceuticals position peaked at $9.61M in Q4 2020.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.